title: Effect of melarsoprol treatment on circulating IL-10 and TNF-alpha levels in human African trypanosomiasis.
abstract: The pathogenesis of human African trypanosomiasis (HAT) has been the object of considerable research interest but has remained incompletely understood. The importance of cytokines in the pathophysiology of this protozoan infection is now widely recognized, but the full spectrum of cytokines involved has yet to be determined. In the present investigation we compared the plasma concentrations of TNF-alpha and IL-10 in normal African controls and patients suffering from advanced meningocephalic (late-stage) Trypanosomiasis brucei (T.b.) gambiense infections, before and after treatment with the arsenical trypanocide melarsoprol. We found that patients with late-stage T. b. gambiense exhibit chronically elevated circulating levels of both of these cytokines, and that these levels quickly decline following melarsoprol treatment. These findings confirm that TNF-alpha is involved in the immunopathogenesis of late-stage African trypanosomiasis and suggest that IL-10 may also play an important regulatory role in this disease.
authors.affiliation: Defence and Civil Institute of Environmental Medicine, Toronto, Ontario, Canada.
authors.forename: S G
authors.initials: SG
authors.lastname: Rhind
authors.forename: B H
authors.initials: BH
authors.lastname: Sabiston
authors.forename: P N
authors.initials: PN
authors.lastname: Shek
authors.forename: A
authors.initials: A
authors.lastname: Buguet
authors.forename: G
authors.initials: G
authors.lastname: Muanga
authors.forename: A
authors.initials: A
authors.lastname: Stanghellini
authors.forename: M
authors.initials: M
authors.lastname: Dumas
authors.forename: M W
authors.initials: MW
authors.lastname: Radomski
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D016753:Interleukin-10 / Q000097:blood*; D008297:Male; D008549:Melarsoprol / Q000494:pharmacology* / Q000627:therapeutic use*; D014344:Trypanocidal Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D014353:Trypanosomiasis, African / Q000097:blood* / Q000503:physiopathology / Q000517:prevention & control; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis* / Q000187:drug effects
chemical_list: D014344:Trypanocidal Agents; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D008549:Melarsoprol